Longitudinal, real-world data to support US FDA submission

A specialist pharmaceutical company commissioned Raremark to recruit a group of people living with pouchitis, a rare gastrointestinal condition, and to track how it affects their lives over a six-month period. The objective was to generate real-world data to support a future regulatory submission to the US FDA, for approval of the company’s investigational drug.

We recruited 44 participants at baseline and retained 37 over the six months. We captured data on the impact of the condition on patients’ day-to-day lives (20 self-reported measures), including: their ability to work/study; physical and emotional aspects; and their relationships with others.

We concluded that a treatment that reduces pouchitis flares could have a positive impact on the quality of life of people living with the condition.

Download the Xperiome case study Longitudinal, real-world data to support US FDA submission. 

Get in touch

Interested in working with us? we’d love to hear from you. Please use the form below to provide us with a few details and we’ll get back in touch with you.

All fields required
Maximum 300 characters

United States office

Five Cowboys Way

Suite 300

Frisco TX 75034

+1 972-382-7227

United Kingdom office

Kemp House

152-160 City Road

London EC1V 2NX

+44 20 3920 9880